Department of Acupuncture, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Literature and Information Section, Shanghai Research Institute of Acupuncture and Meridian, Shanghai 200032, China.
J Integr Med. 2018 Sep;16(5):312-321. doi: 10.1016/j.joim.2018.06.002. Epub 2018 Jun 28.
Migraine without aura (MWoA), the most common type of migraine, has great impacts on quality of life for migraineurs. Acupuncture is used in the treatment and prevention of migraine for its analgesic effects.
The aim of this systematic review and meta-analysis is to systematically assess the therapeutic and preventive effect of acupuncture treatment and its safety for MWoA.
Nine electronic databases (PubMed, MEDLINE, Cochrane Library, Lilacs, Embase, China National Knowledge Infrastructure (CNKI), Chongqing VIP (CQVIP), Wanfang Data and Chinese Clinical Trial Registry (ChiCTR)) were systematically searched from their beginning through June 2017 using MeSH terms such as "acupuncture, acupuncture therapy, electro-acupuncture, ear acupuncture, acupuncture points, acupuncture analgesia," and "migraine disorders, cluster headache." Manual searching included other conference abstracts and reference lists.
Randomized controlled trials (RCTs) with a clinical diagnosis of MWoA, which were treated with acupuncture versus oral medication or sham acupuncture treatment.
Two evaluators screened and collected literature independently; they extracted information on participants, study design, interventions, follow-up, withdrawal and adverse events and assessed risk of bias and quality of the acupuncture intervention. The primary outcomes were frequency of migraine (FM) and number of migraine days (NM). Secondary outcomes included the visual analogue scale (VAS) score, effective rate (ER) and adverse events. Pooled estimates were calculated as mean difference (MD) with 95% confidence interval (CI) for continuous data and relative risk (RR) with 95% CI for dichotomous data.
Overall, 14 RCTs including 1155 participants were identified. The analysis found that acupuncture had a significant advantage over medication in reducing FM (MD = -1.50; 95% CI: -2.32 to -0.68; P < 0.001) and VAS score (MD = 0.97; 95% CI: 0.63-1.31; P < 0.00001) and had a higher ER (RR = 1.30; 95% CI: 1.16-1.45; P < 0.00001). Acupuncture also had a significant advantage over sham acupuncture in the decrease of FM (MD = -1.05; 95% CI: -1.75 to -0.34; P = 0.004) and VAS score (MD = -1.19; 95% CI: -1.75 to -0.63; P < 0.0001). Meanwhile, acupuncture was more tolerated than medication because of less side effect reports (RR = 0.29; 95% CI: 0.17-0.51; P < 0.0001). However, the quality of evidence in the included studies was mainly low (to very low), making confidence in the FM and VAS score results low.
Our meta-analysis shows that the effectiveness of acupuncture is still uncertain, but it might be relatively safer than medication therapy in the treatment and prophylaxis of MWoA. Further proof is needed.
无先兆偏头痛(MWoA)是最常见的偏头痛类型,对偏头痛患者的生活质量有很大影响。针刺因其镇痛作用而被用于偏头痛的治疗和预防。
本系统评价和荟萃分析旨在系统评估针刺治疗 MWoA 的疗效和安全性。
我们系统地检索了 9 个电子数据库(PubMed、MEDLINE、Cochrane 图书馆、Lilacs、Embase、中国知网(CNKI)、重庆维普(CQVIP)、万方数据和中国临床试验注册中心(ChiCTR)),从它们的开始时间到 2017 年 6 月,使用了“针刺、针刺疗法、电针刺、耳针刺、针刺穴位、针刺镇痛”和“偏头痛障碍、丛集性头痛”等 MeSH 术语。手动搜索包括其他会议摘要和参考文献列表。
临床诊断为 MWoA 的随机对照试验(RCT),采用针刺与口服药物或假针刺治疗进行治疗。
两名评估员独立筛选和收集文献;他们提取了参与者、研究设计、干预措施、随访、退出和不良事件的信息,并评估了偏倚风险和针刺干预的质量。主要结局是偏头痛发作频率(FM)和偏头痛天数(NM)。次要结局包括视觉模拟评分(VAS)、有效率(ER)和不良反应。连续数据采用均数差(MD)和 95%置信区间(CI)进行汇总估计,二分类数据采用相对危险度(RR)和 95%CI 进行汇总估计。
共纳入 14 项 RCT,包括 1155 名参与者。分析发现,与药物治疗相比,针刺在降低 FM(MD= -1.50;95%CI:-2.32 至-0.68;P<0.001)和 VAS 评分(MD= 0.97;95%CI:0.63 至 1.31;P<0.00001)方面具有显著优势,并且 ER 更高(RR= 1.30;95%CI:1.16 至 1.45;P<0.00001)。针刺与假针刺相比,在降低 FM(MD= -1.05;95%CI:-1.75 至-0.34;P= 0.004)和 VAS 评分(MD= -1.19;95%CI:-1.75 至-0.63;P<0.0001)方面也具有显著优势。同时,由于不良反应报告较少,针刺比药物治疗更耐受(RR= 0.29;95%CI:0.17 至 0.51;P<0.0001)。然而,纳入研究的证据质量主要为低(至极低),因此对 FM 和 VAS 评分结果的信心较低。
我们的荟萃分析表明,针刺的疗效仍不确定,但在治疗和预防 MWoA 方面,针刺可能比药物治疗相对更安全。需要进一步的证据。